GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar iceman7403 (58.79) Submitted: 5/7/2007 5:50:39 PM : Outperform Start Price: $19.82 GTXI Score: -77.26

great pipeline and collaborations with large pharmas

Featured Broker Partners


Advertisement